Navigation Links
HIV Treatment Said to Increase Heart Attack Risk

A common treatment option for HIV patients is associated with an increased risk for a heart attack, according to a new study. However, researchers say the benefit of the treatment outweighs the risk of a //heart attack for most patients.

Combination antiretroviral therapy substantially improves the prognosis of HIV-infected patients at risk for AIDS. Before this therapy was available, the annual mortality rate among patients with HIV infection exceeded 20 percent.

In the current research, the mortality rate was 2 percent. While the benefits of combination antiretroviral therapy are clear, there is a concern about the treatment being associated with adverse side effects. These side effects include high cholesterol and triglycerides, insulin resistance and diabetes. These problems can lead to cardiovascular problems.

Researchers in Denmark conducted a study to determine if exposure to combination antiretroviral treatment increases the risk of a heart attack. They looked at information on more than 23,000 patients from 11 previous studies. They collected follow-up information on the patients about their HIV and if they had suffered a heart attack.

Researchers collected data over a period of 36,199 person-years. They found 126 patients had a heart attack. They say the incidence of a heart attack increased with longer exposure to combination antiretroviral therapy. They also say factors such as older age, current or former smoking, previous cardiovascular disease and male sex also increased the risk for a heart attack. Furthermore, a higher cholesterol level, a higher triglyceride level and diabetes were associated with an increased risk for a heart attack.

Investigators conclude combination antiretroviral therapy was independently associated with a 26-percent increase in the rate of a heart attack. However, they point out the risk has to be balanced against the benefits from the antiretroviral treatment. They add tha t heart disease can take decades to develop, so further follow-up research is needed to determine the absolute risk of cardiovascular disease.


'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... ... to expand access to affordable hearing aids , increase industry transparency, and ... in the United States. , “For the average consumer, the hearing aid industry ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... sealing company , is proud to announce that many of their franchises have ... customer service. The hard surface restoration franchises received customer recognition through positive reviews ...
(Date:2/8/2016)... ... 08, 2016 , ... The Federal Laboratory Consortium for Technology ... site houses a wealth of federal resources that businesses can leverage to further ... transfer (T2). As a network of over 300 federal laboratories, the FLC’s mission ...
(Date:2/8/2016)... ... ... who has struggled to quit smoking, a man who has struggled with hair loss – ... his problems – and he did. Now Nabat, a serial entrepreneur featured as the October ... to the world and better people's lives. His own experience with nicotine addiction led to ...
(Date:2/8/2016)... ... 2016 , ... The Bell Agency, a full service insurance ... their ongoing community enrichment program. The current campaign fundraises for Angels & Doves, ... being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was founded in ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... DUBLIN , Feb. 9, 2016  Jazz Pharmaceuticals ... will report its 2015 fourth quarter and full year ... close of the financial markets.  Company management will host ... 4:30 p.m. EST/9:30 p.m. GMT to discuss fourth quarter ... business and financial update and guidance for 2016 financial ...
(Date:2/9/2016)... February 9, 2016 Amarantus BioScience ... on developing products for Regenerative Medicine, Neurology and Orphan ... presenting company at Source Capital Group,s 2016 Disruptive Growth ... 2016 in New York City . ... 10, 2016 at 12:30 pm by Gerald E. ...
(Date:2/9/2016)... , Feb. 9, 2016 The new report "Global Blood Monitoring ... Acuity Business Research & Consulting group reveals that global market for ... million in 2014 and expected to grow to US$ 24,830.1 million ... North America , Europe ... , Middle-East and Africa ...
Breaking Medicine Technology: